Friday, July 20, 2018 4:34:40 PM
I've seen Roche buy into Genentech, then buy them out, then spin them out, then buy them out again. The point is that big Pharma has frequently partnered with companies, often taking a substantial interest with the purchase of say 20 to 40% of the stock, this by itself gives them a major say as to how the company functions. In a voting situation, it's almost impossible to defeat a measure supported by someone controlling 30% of the stock.
Either drug in trials today could bring such a partnership, together they'd bring more. The question is, how much would it take, and that's where I believe we'd be talking billions, immediately giving the company a multi-billion dollar market cap. I don't know if, or when such action may occur, but I don't think you can deny the possibility of it happening, and if you cannot do that, you cannot deny the possibility of a multi-billion dollar market cap in the near term future.
Gary
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM